Clinical Trial Update: Tenofovir Alafenamide Versus Tenofovir Disoproxil Fumarate for Treatment of Hepatitis B e Antigen-Positive Hepatitis B (China) [Phase 3]

View source ↗

Summary

This Phase 3 trial compares Tenofovir alafenamide (TAF) with Tenofovir disoproxil fumarate (TDF) for treating chronic hepatitis B in HBeAg-positive patients in …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• TENOFOVIR DISOPROXIL FUMARATE (tenofovir disoproxil fumarate)
• Tenofovir alafenamide (tenofovir alafenamide)

Snippet

Sponsor: Gilead Sciences | Conditions: HBV, Chronic HBV Infection | Phase 3 | Status: COMPLETED | Results posted: 2018-04-17